Biocon’s Bengaluru Biosimilars Plant Cleared For EU
Company Expands Production Capacity For Pegfilgrastim And Trastuzumab
• By Akriti Seth
After receiving GMP approval for its manufacturing sites, Biocon will further focus on EU markets • Source: Shutterstock 
